Constructive operation of jaw bone for implant treatment becomes complex depending on the defect area of the bone getting larger and giving patients pain. We encountered a case of implant treatment after operation of ossifying fibroma in a 28-year-old Japanese woman.
Introduction
Various therapeutic methods such as guided bone regeneration (GBR) and sinus lift have been implemented based upon improvements in implant treatment (1) (2) (3) (4) . As the reconstruction of the jaw is complicated and burdens the patients with physical stress depending on the size of the bone defects, the concept of a technique for the minimum limit of stress is necessary for implant treatment.
Ossifying fibroma, classified into bone-related lesions in odontogenic tumors, affects the jaw and causes bone loss(5), therefore, bone regeneration and prosthodontics after surgery of the tumor are needed for the complete restoration (6, 7) . However, implant treatment of GBR using an atelocollagen sponge and barrier membrane for ossifying fibroma has not been performed as of yet.
We encountered an implant case with tooth extraction and ossifying fibroma and obtained an improved prognosis by making planning and performing a unique method, therefore, interesting and important knowledge is described in this report.
Case summary
The patient provided informed consent after the summary and purpose of the case report was explained to her.
1) Clinical course and extirpation of tumorous lesion
A 28-year-old woman visited our dental clinic with a chief complaint of diffuse pain of the teeth. There were no particular familial or medical histories. A radiolucent tumorous lesion with slight expansion was found in the second premolar-to-first molar region of the left-mandible (Fig. 1a) . There was no evidence of root resorption. The second premolar tooth and mesial root of the first molar tooth were extracted, and the tumorous lesion was extirpated from the socket of the tooth extraction under local anesthesia. After bone elimination, a shell-shape atelocollagen sponge (M size; TERUMO, Tokyo, Japan) was inserted into the extirpated-defect area and the surface was covered with a resorbable barrier membrane (GORE-TEXTM, R6, W.L.Gore and Assoiciates Inc., USA).
Histopathologically, the extirpated lesion consisted of proliferating fibroblastic cells with an irregularly bundlelike arrangement and formation of bony and cementum-like hard tissues, corresponding to ossifying fibroma as a definitive diagnosis (Fig. 1b) . The hard tissues resembled woven bone and/or cellular and acellular cementum adjacent to the proliferating fibroblastic cells.
2) Treatment of implant and GBR
There were no particular symptoms for 5 months after the extirpation of the tumor, therefore, implant treatment (Fig. 2b,c) In order to examing the condition of the implant area, a Periotest ® (Siemens, Germany) was performed in the areas of the second premolar and first molar each week from immediately following to 8 weeks after the implant treatment (Fig. 3a) . Although the data exhibited a high level at immediately after the implant treatment, it gradually decreased and reached a minimum level at 8 weeks, and bone regeneration was almost stable in the area of the surgery (Fig. 3b) .
As the e-PTFE membrane was partly exposed, 0.2% chlorhexidine (KENEI Pharmaceutical, Osaka, Japan) was used as a gargle for 2 weeks in order to protect against infection and for oral hygiene. The reason why 2 % chlorhexidine was not used in the present case was to avoid adverse effects such as hairy tongue, discoloration of teeth, urticaria, and so on, and effectiveness of 0.2% chlorhexidine for oral hygiene could be expected. After the dissection of the alveolar mucosa, the e-PTFE membrane was removed under local anesthesia at 1 month after the implant treatment. Bone formation was observed in the area underneath the membrane. Finally, the dissected mucosa was sutured. The final status is shown in Fig. 4a-c .
Discussion
The present case reached to obtain effective prosthodontical restoration of implant treatment at a total of 7 months after surgery of ossifying fibroma. In the present case, the implant treatment started at 5 months after the surgery. Therefore, an autogenous iliac bone graft might be adequate for these cases after resection of the tumors. In the present case, the tumor, which was definitively diagnosed as an ossifying fibroma, was completely resected at a minimum aggressive approach and no recurrence of the tumor has been confirmed, to date. The present results suggest that implant treatment with an atelocollagen sponge resorbable barrier membrane after surgery is an adequate method for local resection from a viewpoint of restorative treatment.
Several investigators reported that the atelocollagen sponge is not only resorbable and non-immunogenic but also provides a three-dimensional structure scaffold for new bone formation (11) (12) (13) . In the present case, filling the The present case could also obtain complete wound healing and close attachment of the surgically injured tissues and resorbable barrier membrane in GBR. We thought that if a non-resorbable membrane was used, the membrane would be easy to be exposed without close attachment to the injured tissues, causing bacterial infection (17) . In transplantation of the implant compared to GBR, a non-resorbable barrier membrane was applied. The purpose of the non-barrier membrane was in expectation and for confirmation of bone formation and regeneration in the cervical area of the implants before the setting of the upper construction.
As a HA-coated Titanium implant (AQB implant ® ) was used in the present case it could be receive rapid approval.
The results of the Periotest ® , gradually decreased and reached a minimum level at 8 weeks after the surgery.
These results also support that the implant system could provide smooth osseointegration and protect the tissues around the implant from bacterial infection and inflammation.
In the present operation of implant transplantation, the degree of defect was little, and it was easy to perform GBR to accelerate bone formation and regeneration. If the defect was remarkable, the operation could be more complex, such as our previous report (18) . Therefore, we conclude that, for obtaining high quality of implant treatment with extirpation of tumor and tooth extraction, the planning of the treatment should be considered to consider the minimum level of bone loss by extirpation and extraction.
